1. Home
  2. ESPR vs NOA Comparison

ESPR vs NOA Comparison

Compare ESPR & NOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • NOA
  • Stock Information
  • Founded
  • ESPR 2008
  • NOA 1953
  • Country
  • ESPR United States
  • NOA Canada
  • Employees
  • ESPR N/A
  • NOA N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • NOA Meat/Poultry/Fish
  • Sector
  • ESPR Health Care
  • NOA Consumer Staples
  • Exchange
  • ESPR Nasdaq
  • NOA Nasdaq
  • Market Cap
  • ESPR 534.3M
  • NOA 478.5M
  • IPO Year
  • ESPR 2013
  • NOA 2006
  • Fundamental
  • Price
  • ESPR $2.97
  • NOA $15.58
  • Analyst Decision
  • ESPR Buy
  • NOA
  • Analyst Count
  • ESPR 6
  • NOA 0
  • Target Price
  • ESPR $6.50
  • NOA N/A
  • AVG Volume (30 Days)
  • ESPR 7.1M
  • NOA 103.4K
  • Earning Date
  • ESPR 11-06-2025
  • NOA 11-12-2025
  • Dividend Yield
  • ESPR N/A
  • NOA 2.20%
  • EPS Growth
  • ESPR N/A
  • NOA N/A
  • EPS
  • ESPR N/A
  • NOA 0.87
  • Revenue
  • ESPR $268,125,000.00
  • NOA $919,386,154.00
  • Revenue This Year
  • ESPR $18.83
  • NOA $12.11
  • Revenue Next Year
  • ESPR N/A
  • NOA $6.35
  • P/E Ratio
  • ESPR N/A
  • NOA $18.06
  • Revenue Growth
  • ESPR N/A
  • NOA 14.15
  • 52 Week Low
  • ESPR $0.69
  • NOA $12.12
  • 52 Week High
  • ESPR $3.94
  • NOA $22.08
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 59.21
  • NOA 61.73
  • Support Level
  • ESPR $2.80
  • NOA $15.13
  • Resistance Level
  • ESPR $3.11
  • NOA $15.79
  • Average True Range (ATR)
  • ESPR 0.17
  • NOA 0.42
  • MACD
  • ESPR 0.01
  • NOA 0.09
  • Stochastic Oscillator
  • ESPR 76.47
  • NOA 91.18

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About NOA North American Construction Group Ltd. (no par)

North American Construction Group Ltd is Canada's heavy civil construction and mining contractor provider. The company has provided services to oil, natural gas, and resource companies. The Company provides a wide range of mining and heavy civil construction services to customer in the resource development and industrial construction sectors within Canada, the United States, and Australia. The Company's reportable segments are Heavy Equipment Canada, Heavy Equipment Australia, and Other. Heavy Equipment Canada and Heavy Equipment Australia include all of aspects of the mining and heavy civil construction services provided within those geographic areas. Other includes mine management contract work in the United States, its external maintenance and rebuild programs.

Share on Social Networks: